Skip to main content
. Author manuscript; available in PMC: 2014 Mar 20.
Published in final edited form as: Gastrointest Endosc. 2011 Nov 17;75(1):23–31.e2. doi: 10.1016/j.gie.2011.08.042

Table 2.

Utilization of endoscopic surveillance in patients with Barrett’s esophagus, stratified by study site.

Variable Overall
n=235
Mayo
n=79
SAVAMC
n=75
UNC
n=81
Years with BE (mean ± SD) 6.5 ± 5.9 5.2 ± 5.4 9.3 ± 6.2 5.2 ± 5.2
Endoscopy after BE diagnosis
 Yes (n (%)) 211 (92.1) 68 (87.2) 69 (94.5) 74 (94.9)
 No (n (%)) 18 (7.9) 10 (12.8) 4 (5.5) 4 (5.1)
Total surveillance endoscopies (mean ± SD) 4.0 ± 4.0 3.1 ± 2.8 5.3 ± 5.1 3.8 ± 3.7
Months per endoscopy (mean ± SD) 20.2 ± 16.8 20.9 ± 18.6 25.4 ± 14.2 14.3 ± 15.5
Surveillance endoscopies per 2 year period (mean ± SD) 1.8 ± 1.7 1.5 ± 1.0 1.1 ± 0.7 2.8 ± 2.5
Surveillance endoscopies per 3 year period (mean ± SD) 2.7 ± 2.6 2.2 ± 1.5 1.7 ± 1.0 4.2 ± 3.7
>1 endoscopic surveillance per 2 year period (n (%)) 70 (44.9) 20 (37.7) 16 (29.6) 34 (69.4)
>1 endoscopic surveillance per 3 year period (n (%)) 102 (65.4) 30 (56.6) 31 (57.4) 41 (83.7)

Patients with BE<6 months were excluded from these analyses.

Discounting a single confirmatory endoscopy following BE diagnosis

Mayo: Mayo Clinic, Rochester, MN; SAVAMC: Southern Arizona VA medical Center, Tucson AZ; UNC: University of North Carolina Hospitals, Chapel Hill, NC

BE=Barrett’s esophagus

SD=standard deviation